Effectiveness of a third dose of BNT162b2 anti‐SARS‐CoV‐2 mRNA vaccine over a 6‐month follow‐up period in allogenic hematopoietic stem cells recipients.

Autor:	Chevallier, Patrice, Jullien, Maxime, Peterlin, Pierre, Garnier, Alice, Le Bourgeois, Amandine, Coste‐Burel, Marianne, Béné, Marie C., Guillaume, Thierry
Předmět:	HEMATOPOIETIC stem cells COVID-19 vaccines MESSENGER RNA VACCINES HEMATOPOIETIC stem cell transplantation
Zdroj:	Hematological Oncology; Dec2022, Vol. 40 Issue 5, p1097-1099, 3p
Abstrakt:	This study reports the effectiveness of three injections of BNT162b2 anti‐SARS‐CoV‐2 mRNA vaccine in 141 Allo‐HSCT recipients with a median follow‐up of 6 months post‐third shot. We demonstrate a long‐term high protection of Allo‐HSCT recipients since only 2 infections and one death related to COVID‐19 occurred. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text